The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
Open accessAbstract
Metformin is a widely used antidiabetic drug for type 2 diabetes that can play a cardioprotective role through multiple pathways.It is a recognized agonist of AMP-activated protein kinase (AMPK) that blocks mitochondrial complex I.The NLRP3 inflammasome has been demonstrated to be activated in diabetic cardiomyopathy (DCM).However, the role of metformin in regulating the NLRP3 signaling pathway in DCM remains unclear.It has been reported that AMPK can inhibit NLRP3 by activating autophagy.The aim of this study was to investigate whether metformin can inhibit the NLRP3 inflammasome by activating the AMPK/mTOR pathway in DCM.In this study, streptozotocin-induced C57BL/6 mice and high glucose-treated primary cardiomyocytes from neonatal mice were treated with metformin or an AMPK inhibitor compound C. Echocardiography, hematoxylin-eosin and Masson staining showed that the function and morphology of the diabetic hearts were improved after metformin treatment, whereas these parameters deteriorated after intervention with an AMPK inhibitor.Immunohistochemical staining, immunofluorescence staining and western blot assays indicated that the expression levels of mTOR, NLRP3, caspase-1, IL-1β and GSDMD-N were decreased in the diabetic model treated with metformin and were reversed after the administration of an AMPK inhibitor in vivo and in vitro.Mechanistically, our results demonstrated that metformin can activate AMPK, thus improving autophagy via inhibiting the mTOR pathway and alleviating pyroptosis in DCM.Thus, we provide novel information for the treatment of DCM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Journal of The American College of Cardiology
(2015) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2015.03.023 · Cited by 2,584
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism
Cabreiro, F., Au, C., Leung, K.-Y., Vergara-Irigaray, N., Cochemé, H. M., Noori, T., Weinkove, D., Schuster, E., Greene, N. D. E., & Gems, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.035 · Cited by 967
Diabetic cardiomyopathy, causes and effects
Boudina, S., & Abel, E. D. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9131-7 · Cited by 728
Xie, Z., Lau, K., Eby, B., Lozano, P., He, C., Pennington, B., Li, H., Rathi, S., Dong, Y., Tian, R., et al. (2011) · Diabetes · doi:10.2337/db10-0351 · Cited by 490
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3471 · Cited by 450
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., & An, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104771 · Cited by 408
Ye, Y., Bajaj, M., Yang, H.-C., Perez-Polo, J. R., & Birnbaum, Y. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6725-2 · Cited by 368
Li, X., Du, N., Zhang, Q., Li, J., Chen, X., Liu, X., Hu, Y., Qin, W., Shen, N., Xu, C., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.430 · Cited by 315
Xie, Z., Dong, Y., Scholz, R., Neumann, D., & Zou, M.-H. (2008) · Circulation · doi:10.1161/circulationaha.107.744490 · Cited by 273
Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy
Yang, F., Qin, Y., Lv, J., Wang, Y., Che, H., Chen, X., Jiang, Y., Li, A., Sun, X., Yue, E., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1029-4 · Cited by 273
Self-citationMetformin attenuates cardiac fibrosis by inhibiting the TGFβ1–Smad3 signalling pathway
Xiao, H., Ma, X., Feng, W., Fu, Y., Lu, Z., Xu, M., Shen, Q., Zhu, Y., & Zhang, Y. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq066 · Cited by 231
Harris, J., Lang, T., Thomas, J. P. W., Sukkar, M. B., Nabar, N. R., & Kehrl, J. H. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.02.013 · Cited by 222
Li, Y., Li, J., Li, S., Li, Y., Wang, X., Liu, B., Fu, Q., & Ma, S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.010 · Cited by 221
Self-citationSharma, A., Tate, M., Mathew, G., Vince, J. E., Ritchie, R. H., & de Haan, J. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00114 · Cited by 215
NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
Luo, B., Huang, F., Liu, Y., Liang, Y., Wei, Z., Ke, H., Zeng, Z., Huang, W., & He, Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00519 · Cited by 213
Wang, Y., Liu, X., Shi, H., Yu, Y., Yu, Y., Li, M., & Chen, R. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.13 · Cited by 202
Self-citationAMP-Activated Protein Kinase and Autophagy
Meijer, A. J., & Codogno, P. (2007) · Autophagy · doi:10.4161/auto.3710 · Cited by 166
Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
Zhong, Z., Sánchez‐López, E., & Karin, M. (2016) · PubMed · Cited by 156
Metabolic Roles of AMPK and Metformin in Cancer Cells
Choi, Y. K., & Park, K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0169-8 · Cited by 151
Luo, B., Li, B., Wang, W., Liu, X., Liu, X., Xia, Y., Zhang, C., Zhang, Y., Zhang, M., & An, F. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6498-1 · Cited by 150
Qiu, J., Wang, M., Zhang, J., Cai, Q., Lu, D., Li, Y., Dong, Y., Zhao, T., & Chen, D. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.09.024 · Cited by 147
Self-citationAMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome
Bullón, P., Alcocer‐Gómez, E., Carrión, Á. M., Marín‐Aguilar, F., Garrido‐Maraver, J., Román-Malo, L., Ruíz-Cabello, J., Čulić, O., Ryffel, B., Apétoh, L., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6120 · Cited by 125
A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes
Jentzsch, C., Leierseder, S., Loyer, X., Flohrschütz, I., Sassi, Y., Hartmann, D., Thum, T., Laggerbauer, B., & Engelhardt, S. H. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.010 · Cited by 114
Xie, Y., Huang, Y., Ling, X., Qin, H., Wang, M., & Luo, B. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00381 · Cited by 112
Mitophagy in Cardiovascular Diseases
Morciano, G., Patergnani, S., Bonora, M., Pedriali, G., Tarocco, A., Bouhamida, E., Marchi, S., Ancora, G., Anania, G., Wieckowski, M. R., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030892 · Cited by 110
Xie, Z., Dong, Y., Zhang, J., Scholz, R., Neumann, D., & Zou, M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01417-08 · Cited by 105
Berberine Hydrochloride Prevents Postsurgery Intestinal Adhesion and Inflammation in Rats
Zhang, Y., Li, X., Zhang, Q., Li, J., Ju, J., Du, N., Liu, X., Chen, X., Cheng, F., Yang, L., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.212795 · Cited by 98
Guo, S., Meng, X., Yang, X., Liu, X., Ouyang, C., & Liu, C. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.92 · Cited by 97
Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Chatelier, E. L., Sunagawa, S., Prifti, E., Vieira‐Silva, S., Guðmundsdóttir, V., Pedersen, H., et al. (2017) · Nature · doi:10.1038/nature22318 · Cited by 67
Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts
Verma, S., & McNeill, J. H. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.2.h714 · Cited by 59
Mutually inhibitory Ras-PI(3,4)P 2 feedback loops mediate cell migration
Li, X., Edwards, M., Swaney, K. F., Singh, N., Bhattacharya, S., Borleis, J. A., Yu, L., Iglesias, P. A., Chen, J., & Devreotes, P. N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809039115 · Cited by 54
Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
Yang, Z., Wang, M., Zhang, Y., Cai, F., Jiang, B., Zha, W., & Yu, W. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00425 · Cited by 53
Metformin Improves Cardiac Functional Recovery After Ischemia in Rats
Legtenberg, R. J., Houston, R. J. F., Oeseburg, B., & Smits, P. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-26705 · Cited by 51
Pham, D., Raut, P. K., Pandit, M., Chang, J., Katila, N., Choi, D., Jeong, J., & Park, P. (2020) · Cancers · doi:10.3390/cancers12030613 · Cited by 50
Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide
Belcher, G., Lambert, C., Goh, K. L., Edwards, G., & Valbuena, M. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00291.x · Cited by 39
Zhang, Y., Li, J., Li, J., Zhang, Q., Chen, X., Liu, X., Zhang, H., Zhang, H., Yang, H., Hu, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep34284 · Cited by 22
Cited by
Xian, H., Liu, Y., Rundberg Nilsson, A., Gatchalian, R., Crother, T. R., Tourtellotte, W. G., Zhang, Y., Aleman-Muench, G. R., Lewis, G., Chen, W., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.004 · Cited by 407
Self-citationPyroptosis in health and disease: mechanisms, regulation and clinical perspective
Liu, Y., Pan, R., Ouyang, Y., Gu, W., Xiao, T., Yang, H., Tang, L., Wang, H., Xiang, B., & Chen, P. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01958-2 · Cited by 337
Mishra, S. R., Mahapatra, K. K., Behera, B. P., Patra, S., Bhol, C. S., Panigrahi, D. P., Praharaj, P. P., Singh, A., Patil, S., Dhiman, R., et al. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106013 · Cited by 195
The Signaling Pathways Regulating NLRP3 Inflammasome Activation
Chen, M.-Y., Ye, X.-J., He, X.-H., & Ouyang, D.-Y. (2021) · Inflammation · doi:10.1007/s10753-021-01439-6 · Cited by 154
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Jung, E. S., Choi, H., & Mook-Jung, I. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00825-0 · Cited by 124
Metadata
- Authors
- Yang, F., Qin, Y., Wang, Y., Meng, S., Xian, H., Che, H., Lv, J., Li, Y., Yu, Y., Bai, Y., & Wang, L.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2019
- Volume
- 15
- Issue
- 5
- Pages
- 1010-1019
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2923199598
- Cited by
- 461
- References
- 45
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.